Company Filing History:
Years Active: 2011-2015
Title: Suzanne P McKenzie: Innovator in Cancer Treatment
Introduction
Suzanne P McKenzie is a prominent inventor based in West Newton, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of interleukin-12p40 variants. With a total of 3 patents, her work focuses on enhancing the stability of therapeutic proteins.
Latest Patents
One of her latest patents is titled "Methods of treating cancer using interleukin-12p40 variants having improved stability." This patent discloses modified interleukin-12 (IL-12) p40 polypeptides that have alterations in the IL-12p40 subunit. These modifications eliminate the protease site between positions Lys260 and Arg261, resulting in improved stability compared to wild-type mature human IL-12p40 polypeptides. Another significant patent is "Nucleic acids encoding interleukin-12P40 variants with improved stability," which shares similar advancements in the stability of modified IL-12p40 polypeptides.
Career Highlights
Suzanne P McKenzie is currently associated with Merck Patent GmbH, where she continues her research and development efforts. Her work has been instrumental in advancing cancer treatment methodologies, showcasing her dedication to improving patient outcomes.
Collaborations
Some of her notable coworkers include Gordon D Webster and Kin-Ming Lo, who have collaborated with her on various projects related to her patents.
Conclusion
Suzanne P McKenzie is a trailblazer in the field of cancer treatment, with her innovative patents reflecting her commitment to scientific advancement. Her contributions are paving the way for more effective therapies in the fight against cancer.